产品名称 | NebuSelect™ Recombinant Human EPHA4, His-tag |
---|---|
目录号 | NBL-240873 |
别名 | EPHA4; Sek; Sek1; EphA4; HEK8; SEK; TYRO1; EK8 |
外观 | see COA |
分子量 | Val20-Thr547 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P54764-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240873-100ug | 100ug | Inquire | Inquire | |
NBL-240873-1mg | 1mg | Inquire | Inquire | |
NBL-240873-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human EPHA4, His-tag
Catalog#:
NBL-240873
Description:
NebuSelect™ Recombinant Human EPHA4, His-tag(Cat#NBL-240873) is expressed in HEK293 with His tag at the C-Terminus.It contains Val20-Thr547.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 59.5 kDa. Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result.
Target Name:
EPHA4; Sek; Sek1; EphA4; HEK8; SEK; TYRO1; EK8
Target Information:
The expression and activation of EphA4 in the various cell types in a knee joint was upregulated upon an intraarticular injury. To determine if EphA4 signaling plays a role in osteoarthritis, we determined whether deficient EphA4 expression (in EphA4 knockout mice) or upregulation of the EphA4 signaling (with the EfnA4-fc treatment) would alter cellular functions of synoviocytes and articular chondrocytes. In synoviocytes, deficient EphA4 expression enhanced, whereas activation of the EphA4 signaling reduced, expression and secretion of key inflammatory cytokines and matrix metalloproteases.
Amino Acid Sequence:
Val20-Thr547
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.